Brolucizumab Protocol for Chronic Central Serous Chorioretinopathy Compared to Multivitamins
Doctors test new eye drug for stubborn fluid without neovascularization
This protocol describes a randomized controlled trial comparing intravitreal brolucizumab to oral multivitamins in 42 patients with chronic …
A new eye drug trial could help people with stubborn fluid in their retina by comparing it to vitamins in a strict study.
Post hoc analysis compares brolucizumab and aflibercept for diabetic macular edema
A New Eye Injection Works Even If You've Had Treatment Before
A post hoc analysis of a randomized trial in 517 participants with diabetic macular edema compared intravitreal brolucizumab to aflibercept …
People with diabetic eye disease who have already tried other injections may still get meaningful vision improvement from brolucizumab.